Latest news for Crism Therapeutics (OTC:AMMCF) Stock

Crism Therapeutics Corp has developed a drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. Its product ChemoSeed which is in its clinical trial phase, can be implanted directly into the tumour or the resection margin following the removal of a tumour. The company also provides consultancy and formulation services to its clients assisting them with pharmaceutical formulation and development.

CRISM THERAPEUTICS CORP by CRISM THERAPEUTICS CORP

Comments

Crism Therapeutics

News

Latest news for Crism Therapeutics (OTC:AMMCF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga